Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-09-11

Clinical Trial Update: Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating INGN 201 in combination with chemotherapy versus chemotherapy alone for squamous cell carcinoma; the update discusses effectiveness and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INGN 201

Snippet

Sponsor: Introgen Therapeutics | Conditions: Carcinoma, Squamous Cell | Phase 3 | Status: UNKNOWN